Search Results - "FUKUSHIMA, YOSHIFUMI"

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials by Daida, Hiroyuki, Dohi, Tomotaka, Fukushima, Yoshifumi, Ohmura, Hirotoshi, Miyauchi, Katsumi

“…Enormous effort has been put into the prevention of atherosclerosis through risk modification, especially with lipid-lowering therapies. Regression, that is,…”
Get full text

Effect of Cereal Consumption (Frugra®) on Autonomic Nervous System Function in Healthcare Workers Who Skip Breakfast by EBINA, Hideki, DOHI, Tomotaka, FUKUSHIMA, Yoshifumi, FUKAO, Kosuke, KASAI, Takatoshi, UEDA, Seiji, MATSUSHITA, Satoshi, AMANO, Atsushi, MINAMINO, Tohru

“…In this study, we aimed to clarify the effects of breakfast intervention on autonomic nerve function in healthcare workers who skip breakfast. This…”
Get full text

Safety and efficacy of using cereal food (Frugra®) to improve blood pressure and bowel health in patients undergoing chronic hemodialysis: A pilot study by Nagasawa, Hajime, Ueda, Seiji, Otsuka, Tomoyuki, Kaifu, Kumiko, Ono, Shigeo, Okuma, Teruyuki, Kobayashi, Takashi, Matsushita, Satoshi, Kasai, Takatoshi, Dohi, Tomotaka, Fukushima, Yoshifumi, Amano, Atsushi, Suzuki, Yusuke

“…Hypertension and constipation are major hemodialysis complications. Salt restriction is one of the most important nonpharmacological interventions in managing…”
Get full text

Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention by Konishi, Hirokazu, MD, Miyauchi, Katsumi, MD, Kasai, Takatoshi, MD, PhD, Tsuboi, Shuta, MD, PhD, Ogita, Manabu, MD, PhD, Naito, Ryo, MD, Sai, Eiryu, MD, PhD, Fukushima, Yoshifumi, MD, PhD, Katoh, Yoshiteru, MD, Okai, Iwao, MD, Tamura, Hiroshi, MD, Okazaki, Shinya, MD, Daida, Hiroyuki, MD

“…Cardiovascular risk remains uncertain in patients with cardiovascular disease despite achieving target lipid levels. Serum levels of lipoprotein(a) [Lp(a)] can…”
Get full text

A Comprehensive Approach for Preventing Cardiovascular Events During the Olympic and Paralympic Games by SHIMADA, KAZUNORI, FUKUSHIMA, YOSHIFUMI, FUKAO, KOSUKE, SHIOZAKI, MASAYUKI, HIKI, MAKOTO, AIHARA, KOICHIRO, DAIDA, HIROYUKI

Get full text

Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome by Ohmura, Hirotoshi, Fukushima, Yoshifumi, Mizuno, Atsushi, Niwa, Koichiro, Kobayashi, Yohei, Ebina, Toshiaki, Kimura, Kazuo, Ishibashi, Shun, Daida, Hiroyuki

“…Heterozygous familial hypercholesterolemia (FH) represents a strong risk for development of premature coronary artery disease (CAD). However, the majority of…”
Get full text

A case of adult patent ductus arteriosus‐associated infective endarteritis who was successfully treated with only antibiotics by Kanai, Akira, Chikata, Yuichi, Iwata, Hiroshi, Ajima, Tomohi, Kaneko, Tomohiro, Murata, Azusa, Kagiyama, Nobuyuki, Fukushima, Yoshifumi, Miyazaki, Sakiko, Minamino, Tohru

“…Patent ductus arteriosus‐associated infective endarteritis (PDA‐IE) is an extremely rare complication of PDA in recent years. In this report, we describe a…”
Get full text

Estimated Prevalence of Heterozygous Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome: Multicenter Registration Study in Japan by Ohmura, Hirotoshi, Fukushima, Yoshifumi, Mizuno, Atsushi, Niwa, Koichiro, Kobayashi, Yohei, Ebina, Toshiaki, Kimura, Kazuo, Ishibashi, Shun, Daida, Hiroyuki, on behalf of the Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan

“…Heterozygous familial hypercholesterolemia (FH) represents a strong risk for development of premature coronary artery disease (CAD). However, the majority of…”
Get full text

Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study by Fukushima, Yoshifumi, Daida, Hiroyuki, Morimoto, Takeshi, Kasai, Takatoshi, Miyauchi, Katsumi, Yamagishi, Sho-ichi, Takeuchi, Masayoshi, Hiro, Takafumi, Kimura, Takeshi, Nakagawa, Yoshihisa, Yamagishi, Masakazu, Ozaki, Yukio, Matsuzaki, Masunori

“…The Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS) trial demonstrated that early aggressive statin therapy in…”
Get full text

Ezetimibe decreases serum oxidized cholesterol without impairing bile acid synthesis in Japanese hypercholesterolemic patients by Hirayama, Satoshi, Nakagawa, Saori, Soda, Satoshi, Kamimura, Yumiko, Nishioka, Emiko, Ueno, Tsuyoshi, Fukushima, Yoshifumi, Higuchi, Ken-ichi, Inoue, Masanori, Seino, Utako, Ohmura, Hirotoshi, Yamato, Susumu, Miida, Takashi

“…Abstract Objective Cholesterol and diet-derived oxidized cholesterol are absorbed in the small intestine and eliminated by bile acids. We determined whether…”
Get full text

Non-high-density lipoprotein cholesterol is a practical predictor of long-term cardiac death after coronary artery bypass grafting by Fukushima, Yoshifumi, Ohmura, Hirotoshi, Mokuno, Hiroshi, Kajimoto, Kan, Kasai, Takatoshi, Hirayama, Satoshi, Miyauchi, Katsumi, Miida, Takashi, Amano, Atsushi, Daida, Hiroyuki

“…Highlights ► We investigated predictive value of non-HDL-C for long-term prognosis after CABG. ► Increased non-HDL-C levels are significantly associated with…”
Get full text

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy : Insights from IVUS Trials by Hiroyuki Daida, Tomotaka Dohi, Yoshifumi Fukushima, Hirotoshi Ohmura, Katsumi Miyauchi

“…Enormous effort has been put into the prevention of atherosclerosis through risk modification, especially with lipid-lowering therapies. Regression, that is,…”
Get full text

Single Administration of α-Glucosidase Inhibitors on Endothelial Function and Incretin Secretion in Diabetic Patients With Coronary Artery Disease: Juntendo University Trial: Effects of Miglitol on Endothelial Vascular Reactivity in Type 2 Diabetic Patients With Coronary Heart Disease (J-MACH) by Hiki, Makoto, Shimada, Kazunori, Kiyanagi, Takashi, Fukao, Kosuke, Hirose, Kuniaki, Ohsaka, Hiromichi, Fukushima, Yoshifumi, Kume, Atsumi, Matsumori, Rie, Sumiyoshi, Katsuhiko, Miyazaki, Tetsuro, Ohmura, Hirotoshi, Kurata, Takeshi, Miida, Takashi, Daida, Hiroyuki

“…Background: Post-prandial hyperglycemia, hyperlipidemia, and endothelial dysfunction play an important role in the pathogenesis of atherosclerosis. Improvement…”
Get full text

Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients by Hirayama, Satoshi, Soda, Satoshi, Ito, Yasuki, Matsui, Hiroshi, Ueno, Tsuyoshi, Fukushima, Yoshifumi, Ohmura, Hirotoshi, Hanyu, Osamu, Aizawa, Yoshifusa, Miida, Takashi

“…Type 2 diabetic patients have a higher risk of atherosclerosis than non-diabetic subjects. This difference may be attributable to increased levels of small…”
Get full text

Profiles of inflammatory markers and lipoprotein subclasses in patients undergoing continuous ambulatory peritoneal dialysis by Kon, Mika, Hirayama, Satoshi, Horiuchi, Yuki, Ueno, Tsuyoshi, Idei, Mayumi, Fueki, Yuriko, Seino, Utako, Goto, Shin, Maruyama, Hiroki, Iino, Noriaki, Fukushima, Yoshifumi, Ohmura, Hirotoshi, Hirowatari, Yuji, Miida, Takashi

“…Patients undergoing continuous ambulatory peritoneal dialysis (CAPD) often have inflammation and dyslipidemia that accelerate to atherosclerosis. This study…”
Get full text

Low serum carnitine level is associated with increased urinary carnitine excretion in late pregnancy by Kobori, Yutaro, Hirayama, Satoshi, Fukushima, Yoshifumi, Ueno, Tsuyoshi, Sekihara, Kazumasa, Hori, Atsushi, Horiuchi, Yuna, Makino, Shintaro, Nishioka, Emiko, Miida, Takashi

“…Carnitine is essential for fatty acid metabolism. Free carnitine (FCA) is excreted in the urine in the glomerulus, but is partly reabsorbed by a carnitine…”
Get more information

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials by Daida, Hiroyuki, Dohi, Tomotaka, Fukushima, Yoshifumi, Ohmura, Hirotoshi, Miyauchi, Katsumi

“…Enormous effort has been put into the prevention of atherosclerosis through risk modification, especially with lipid-lowering therapies. Regression, that is,…”
Get full text

Harmonization of Lipoprotein(a) Immunoassays Using A Serum Panel Value Assigned with The IFCC-Endorsed Mass Spectrometry-Based Reference Measurement Procedure as A First Step Towards Apolipoprotein Standardization by Miida, Takashi, Hirayama, Satoshi, Fukushima, Yoshifumi, Hori, Atsushi, Ito, Satomi, Hinata, Masanobu, Wakita, Mitsuru, Tabata, Hiroki, Tamura, Yoshifumi, Watada, Hirotaka, Kawamori, Ryuzo, Vesper, Hubert W, Cobbaert, Christa M

“…Lipoprotein (a) [Lp(a)] is a well-established risk factor for cardiovascular disease independent of low-density lipoprotein-cholesterol (LDL-C). The Lp(a)…”
Get full text

Cover Image by Kanai, Akira, Chikata, Yuichi, Iwata, Hiroshi, Ajima, Tomohi, Kaneko, Tomohiro, Murata, Azusa, Kagiyama, Nobuyuki, Fukushima, Yoshifumi, Miyazaki, Sakiko, Minamino, Tohru

“…The cover image is based on the Case Report A case of adult patent ductus arteriosus‐associated infective endarteritis who was successfully treated with only…”
Get full text

Cover Image by Kanai, Akira, Chikata, Yuichi, Iwata, Hiroshi, Ajima, Tomohi, Kaneko, Tomohiro, Murata, Azusa, Kagiyama, Nobuyuki, Fukushima, Yoshifumi, Miyazaki, Sakiko, Minamino, Tohru

“…The cover image is based on the Case Report A case of adult patent ductus arteriosus‐associated infective endarteritis who was successfully treated with only…”
Get full text